Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease
1999 ◽
Vol 66
(4)
◽
pp. 436-441
◽
2009 ◽
Vol 63
(4)
◽
pp. 613-623
◽